IP Verse

Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof - EP2695609

PATENT ANALYSIS

Patent Details

Grant Date
Dec 11, 2019
Company
CELGENE CORPORATION
Oppositions

GENERICS (U.K.) LIMITED

HOFFMANN EITLE

SANDOZ AG

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Celgene Corporation

EP3370729

EP2651400

EP3880802

Want to monitor this patent?

Feel free to send us a message here and we will get back to you